Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation

NCT00297830 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT00297830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00297830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation
Lead sponsor
Columbia University
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2005
Completion date
January 31, 2014
Enrollment
111 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone resorption, heart transplantation, liver transplantation